Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ULK4 pseudogene 3 (ULK4P3) is formally annotated as a pseudogene related to the ULK4 gene. Unlike ULK4, which is studied for its role in neurogenesis and neuropsychiatric disorders[1][4][7], ULK4P3 has no documented function, no known protein product, and is not considered a receptor, enzyme, transporter, or other therapeutic target. There is minimal literature describing ULK4P3, and its only apparent scientific role is as a reference point or annotation in genomic research[3]. Scientific investigations and therapeutic interest focus on ULK4, and not on ULK4P3. ULK4P3 is a pseudogene with no functional protein product, no known biological role, and is not considered a current or potential therapeutic target. There is something wrong with designating it as a target for drug discovery or clinical research. References focus on ULK4 proper, not the ULK4P3 pseudogene[1][2][3].
None known. No approved or investigational drug mechanisms target ULK4P3.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ULK4 pseudogene 3 (ULK4P3).